M&T Bank Corp Novo Cure LTD Transaction History

M&T Bank Corp

$29.1 Billion
Q2 2024

A detailed history of M&T Bank Corp transactions in Novo Cure LTD stock. As of the latest transaction made, M&T Bank Corp holds 16,019 shares of NVCR stock, worth $250,056. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,019

Previous 15,106 6.04%

Holding current value

$250,056

Previous $236,000 16.1%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$11.83 - $24.05 $10,800 - $21,957	913 Added 6.04%	16,019 $274,000
Q1 2024 May 07, 2024	BUY	$12.42 - $17.29 $187,616 - $261,182	15,106 New	15,106 $236,000
Q2 2023 Aug 09, 2023	BUY	$40.29 - $82.51 $886 - $1,815	22 Added 0.44%	4,979 $206,000
Q1 2023 May 11, 2023	BUY	$56.44 - $118.81 $59,713 - $125,700	1,058 Added 27.14%	4,957 $298,000
Q4 2022 Feb 13, 2023	SELL	$63.98 - $85.37 $64,875 - $86,565	-1,014 Reduced 21.24%	3,761 $275,000
Q4 2022 Feb 13, 2023	BUY	$63.98 - $85.37 $8,829 - $11,781	138 Added 3.67%	3,899 $285,000
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $20,464 - $26,960	-301 Reduced 5.93%	4,775 $350,000
Q2 2022 Aug 05, 2022	SELL	$56.6 - $89.9 $10,923 - $17,350	-193 Reduced 3.66%	5,076 $347,000
Q1 2022 May 09, 2022	BUY	$60.15 - $84.52 $137,863 - $193,719	2,292 Added 76.99%	5,269 $435,000
Q4 2021 Feb 07, 2022	BUY	$75.08 - $121.99 $15,841 - $25,739	211 Added 7.63%	2,977 $224,000
Q3 2021 Oct 28, 2021	SELL	$116.17 - $194.55 $44,028 - $73,734	-379 Reduced 12.05%	2,766 $322,000
Q2 2021 Aug 13, 2021	BUY	$130.4 - $225.58 $31,035 - $53,688	238 Added 8.19%	3,145 $697,000
Q1 2021 May 06, 2021	SELL	$124.11 - $190.17 $386,850 - $592,759	-3,117 Reduced 51.74%	2,907 $383,000
Q4 2020 Feb 12, 2021	SELL	$112.16 - $174.14 $14,132 - $21,941	-126 Reduced 2.05%	6,024 $1.04 Million
Q3 2020 Nov 06, 2020	BUY	$58.05 - $111.31 $153,658 - $294,637	2,647 Added 75.56%	6,150 $685,000
Q2 2020 Jul 29, 2020	SELL	$57.2 - $74.41 $286 - $372	-5 Reduced 0.14%	3,503 $208,000
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $9,299 - $15,607	163 Added 4.87%	3,508 $236,000
Q4 2019 Feb 07, 2020	SELL	$68.3 - $93.8 $15,640 - $21,480	-229 Reduced 6.41%	3,345 $282,000
Q3 2019 Nov 12, 2019	SELL	$61.86 - $97.8 $39,528 - $62,494	-639 Reduced 15.17%	3,574 $267,000
Q2 2019 Aug 12, 2019	BUY	$42.22 - $63.23 $548 - $821	13 Added 0.31%	4,213 $266,000
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $134,232 - $235,704	4,200 New	4,200 $202,000

Others Institutions Holding NVCR

# of Institutions

272

Shares Held

77.2M

Call Options Held

751K

Put Options Held

293K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.64B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account